BioWorld MedTech

July 27, 2011

Combination of molecular tests best at detecting thyroid cancer

ATLANTA — A picture displaying what appears to be part of a female's abdomen pops up on the screen – with the words next to it "The fastest growing cancer among women isn't what you think." (Medical Device Daily) Read More

Studies support Cellvizio use in GI, urology, and more

Report from Europe: First five patients treated in TriVascular's OVATION trial

Washington roundup: FDA's 'when-to-file' guidance limits predicates to those cited

Financings roundup: HCA to offer $1 billion of its secured and unsecured notes

MDD's food for med-tech thought

Deals roundup: OraSure buys DNA Genotek for close to $53M in cash

Agreements/contracts: CareFusion to distribute ResMed Stellar ventilators

HIT roundup: New mobile app to help decipher medical tests

Med-Tech Notes

People in the News

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for June 12, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 9, 2026

Pre-disease plasma signature may help redefine lung cancer risk

BioWorld

Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...

New 5-HT2C receptor agonists reported in Hansoh patent

BioWorld Science

Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...

Virtual IPO word with stock graph and arrow

Parabilis takes top spot, pricing largest biopharma IPO at $670M

BioWorld

Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...